Pierre Fabre Pharmaceuticals

Parsippany,  NJ 
United States
  • Booth: 764

Come see Pierre Fabre Pharmaceuticals, Inc. in Booth #527.

Pierre Fabre Pharmaceuticals, Inc. is a US subsidiary of Pierre Fabre Laboratories, the second largest independent pharmaceutical group in France.  Pierre Fabre is present in 42 countries and has distribution in over 130 countries worldwide.  Pierre Fabre Pharmaceuticals, Inc. is committed to the absolute requirement of quality, efficacy and safety of its drugs; research and development of dermatological products; and partnering with dermatologists and pediatricians.

Pierre Fabre Pharmaceuticals, Inc. recently received FDA approval for HEMANGEOL™ (propranolol hydrochloride) Oral Solution with a new pediatric indication.

To find out more about HEMANGEOL™ and Pierre Fabre Pharmaceuticals, please stop by booth #527 in the Exhibit Hall or visit www.hemangeol.com.

Brands: HEMANGEOL™ (propranolol hydrochloride) Oral Solution is a FDA-approved drug with a new pediatric indication.

For technical assistance, please contact support.